Summary
Johnson & Johnson (JNJ) filed an 8-K on October 15, 2024, to report its third-quarter 2024 financial results, which concluded on September 29, 2024. The filing primarily directs investors to the attached press release (Exhibit 99.1) for detailed sales and earnings information. While the 8-K itself does not contain the specific figures, it serves as the official notification and repository for the company's performance disclosure for the quarter.
Key Highlights
- 1Johnson & Johnson filed an 8-K on October 15, 2024, related to its Q3 2024 financial results.
- 2The report covers the third quarter ended September 29, 2024.
- 3Key financial details regarding sales and earnings are provided in an attached press release (Exhibit 99.1).
- 4Additional supplementary sales data and condensed consolidated statements of earnings are also included as exhibits (Exhibit 99.2).
- 5This filing formally announces the company's quarterly performance to the market.
- 6Investors should refer to the referenced exhibits for the specific financial performance data.